Skip to main content
. 2021 Aug 2;18(8):e1003708. doi: 10.1371/journal.pmed.1003708

Table 2. Number of incident cases and PPVs (95% CIs) for cancer and for IBD in the year following each studied abdominal symptom, considering each symptom regardless of other symptoms, or in pairwise combinations with the other examined symptoms*.

Symptom cohort
Pairwise symptom combinations (recorded in the same consultation or up to a year prior)
Men Women
Cancer IBD Cancer IBD
n PPV (%) (95% CI) n PPV (%) (95% CI) n PPV (%) (95% CI) n PPV (%) (95% CI)
Abdominal bloating/distension 450 1.65 (1.50, 1.80) 296 1.09 (0.96, 1.21) 982 1.33 (1.25, 1.42) 733 1.00 (0.92, 1.07)
    Combined with the following:
    Abdominal pain 110 2.53 (2.06, 2.99) 71 1.63 (1.25, 2.01) 207 1.68 (1.46, 1.91) 196 1.59 (1.37, 1.82)
    Change in bowel habit 10 2.21 (0.85, 3.56) 7 1.55 (0.41, 2.68) 24 2.49 (1.50, 3.47) 14 1.45 (0.70, 2.21)
    Dyspepsia 271 1.45 (1.27, 1.62) 186 0.99 (0.85, 1.13) 547 1.05 (0.97, 1.14) 485 0.93 (0.85, 1.02)
    Dysphagia 9 3.91 (1.41, 6.42) <5 <2.17 6 1.13 (0.23, 2.04) 8 1.51 (0.47, 2.55)
    Rectal bleeding 16 2.43 (1.25, 3.60) 20 3.03 (1.73, 4.34) 21 1.64 (0.94, 2.33) 33 2.57 (1.71, 3.44)
Abdominal pain 5,841 1.77 (1.73, 1.82) 3,842 1.17 (1.13, 1.20) 6,749 1.20 (1.17, 1.23) 6,544 1.17 (1.14, 1.19)
    Combined with the following:
    Abdominal bloating/distension 81 2.86 (2.24, 3.47) 34 1.20 (0.80, 1.60) 144 1.86 (1.56, 2.16) 104 1.34 (1.09, 1.60)
    Change in bowel habit 130 4.64 (3.86, 5.42) 84 3.00 (2.37, 3.63) 123 2.68 (2.21, 3.14) 120 2.61 (2.15, 3.07)
    Dyspepsia 337 2.02 (1.81, 2.23) 208 1.25 (1.08, 1.41) 426 1.54 (1.40, 1.69) 359 1.30 (1.17, 1.43)
    Dysphagia 52 3.15 (2.31, 4.00) 26 1.58 (0.98, 2.18) 65 2.24 (1.70, 2.78) 56 1.93 (1.43, 2.43)
    Rectal bleeding 176 3.02 (2.58, 3.46) 215 3.69 (3.21, 4.18) 157 2.03 (1.71, 2.34) 227 2.93 (2.56, 3.31)
Change in bowel habit 2,101 4.64 (4.45, 4.84) 1,278 2.82 (2.67, 2.98) 1,471 2.39 (2.27, 2.51) 1,581 2.57 (2.45, 2.70)
    Combined with the following:
    Abdominal bloating/distension 16 3.29 (1.71, 4.88) 11 2.26 (0.94, 3.59) 26 2.12 (1.31, 2.92) 29 2.36 (1.51, 3.21)
    Abdominal pain 211 4.78 (4.15, 5.41) 111 2.51 (2.05, 2.97) 174 2.10 (1.79, 2.41) 209 2.52 (2.19, 2.86)
    Dyspepsia 66 2.95 (2.25, 3.65) 52 2.32 (1.70, 2.95) 73 1.91 (1.47, 2.34) 112 2.92 (2.39, 3.46)
    Dysphagia 14 4.46 (2.18, 6.74) 10 3.18 (1.24, 5.13) 9 1.88 (0.66, 3.09) 14 2.92 (1.41, 4.43)
    Rectal bleeding 121 8.46 (7.01, 9.90) 93 6.50 (5.22, 7.78) 98 5.22 (4.22, 6.23) 92 4.90 (3.93, 5.88)
Dyspepsia (any) 3,072 1.41 (1.36, 1.46) 1,941 0.89 (0.85, 0.93) 3,091 1.03 (0.99, 1.07) 2,998 1.00 (0.96, 1.03)
    Combined with the following:
    Abdominal bloating/distension 232 1.48 (1.29, 1.67) 164 1.04 (0.89, 1.20) 495 1.10 (1.00, 1.20) 414 0.92 (0.83, 1.01)
    Abdominal pain 363 1.67 (1.50, 1.84) 272 1.25 (1.10, 1.40) 439 1.16 (1.05, 1.27) 492 1.30 (1.19, 1.41)
    Change in bowel habit 35 2.16 (1.46, 2.87) 29 1.79 (1.15, 2.44) 29 1.14 (0.73, 1.55) 56 2.20 (1.63, 2.77)
    Dysphagia 106 2.31 (1.88, 2.75) 37 0.81 (0.55, 1.07) 83 1.74 (1.37, 2.11) 53 1.11 (0.81, 1.41)
    Rectal bleeding 63 1.63 (1.23, 2.03) 78 2.02 (1.58, 2.47) 72 1.73 (1.33, 2.13) 89 2.14 (1.70, 2.58)
Dysphagia 1,601 4.28 (4.07, 4.48) 282 0.75 (0.67, 0.84) 1,041 2.13 (2.01, 2.26) 441 0.90 (0.82, 0.99)
    Combined with the following:
    Abdominal bloating/distension 5 2.25 (0.30, 4.20) <5 <2.32 10 1.59 (0.61, 2.56) <5 <0.78
    Abdominal pain 123 5.10 (4.22, 5.98) 30 1.24 (0.80, 1.69) 101 2.00 (1.61, 2.39) 71 1.41 (1.08, 1.73)
    Change in bowel habit 15 5.36 (2.72, 7.99) <5 <1.83 11 2.53 (1.06, 4.01) 5 1.15 (0.15, 2.16)
    Dyspepsia 149 5.69 (4.80, 6.57) 18 0.69 (0.37, 1.00) 98 2.37 (1.91, 2.84) 35 0.85 (0.57, 1.13)
    Rectal bleeding 25 4.07 (2.50, 5.63) 11 1.79 (0.74, 2.84) 15 2.08 (1.04, 3.12) 11 1.53 (0.63, 2.42)
Rectal bleeding 3,730 3.20 (3.09, 3.30) 3,080 2.64 (2.55, 2.73) 2,911 2.46 (2.37, 2.55) 3,271 2.76 (2.67, 2.86)
    Combined with the following:
    Abdominal bloating/distension 18 2.97 (1.62, 4.32) 22 3.63 (2.14, 5.12) 29 2.04 (1.30, 2.77) 40 2.81 (1.95, 3.67)
    Abdominal pain 225 2.94 (2.56, 3.32) 192 2.51 (2.16, 2.86) 255 1.98 (1.74, 2.22) 367 2.85 (2.56, 3.14)
    Change in bowel habit 94 7.11 (5.73, 8.50) 82 6.20 (4.90, 7.50) 98 5.65 (4.56, 6.74) 108 6.23 (5.09, 7.37)
    Dyspepsia 113 2.45 (2.01, 2.90) 107 2.32 (1.89, 2.76) 102 1.80 (1.45, 2.14) 151 2.66 (2.24, 3.08)
    Dysphagia 13 2.18 (1.01, 3.36) 12 2.02 (0.89, 3.15) 21 2.74 (1.59, 3.90) 25 3.26 (2.01, 4.52)

Counts of cancer <5 or of IBD <5 in Table 2 are not presented, in compliance with reporting standards for minimising disclosivity risk.

* The number of patients with both cancer and IBD in the year following the index abdominal symptom consultation (regardless of prior symptoms) ranged from 7 (men with abdominal bloating/distension or dysphagia) to 95 (women with abdominal pain). See Table 3 for numbers and PPVs for the composite outcome of either cancer or IBD.

CI, confidence interval; IBD, inflammatory bowel disease; PPV, positive predictive value.